Table 2.
RR (95% CI) No BP Meds |
RR (95% CI) BP Meds |
RR (95% CI) No ε4 Allele |
RR (95% CI) Any ε4 Allele |
|
---|---|---|---|---|
N/AD | 912/191 | 1225/246 | 1330/245 | 608/160 |
| ||||
Systolic BP | ||||
Linear Risk | 0.95 (0.90, 1.00) | 1.07 (1.02, 1.12) | 1.02 (0.97, 1.06) | 1.05 (0.98, 1.13) |
SBP Threshold | 150 (148, 153) | 120 (110, 130) | 143 (140, 146) | 141 (138, 144) |
10 mm Hg below | 0.78 (0.72, 0.85) | 0.80 (0.58, 1.09) | 0.88 (0.80, 0.96) | 0.70 (0.62, 0.80) |
10 mm Hg above | 1.30 (1.17, 1.44) | 1.09 (1.04, 1.15) | 1.13 (1.05, 1.21) | 1.43 (1.29, 1.59) |
| ||||
Diastolic BP | ||||
Linear Risk | 0.92 (0.87, 0.97) | 1.07 (1.02, 1.12) | 1.02 (0.97, 1.07) | 1.03 (0.97, 1.09) |
DBP Threshold | 84 (80, 88) | 76 (74, 78) | – | 76 (74, 78) |
5 mm Hg below | 0.90 (0.84, 0.96) | 0.92 (0.83, 1.01) | – | 0.74 (0.66, 0.83) |
5 mm Hg above | 1.03 (0.84, 1.26) | 1.18 (1.10, 1.27) | – | 1.32 (1.20, 1.44) |
| ||||
No ε4 Allele | Any ε4 Allele | |||
No BP Meds | BP Meds | No BP Meds | BP Meds | |
| ||||
N/AD | 585/105 | 745/140 | 245/70 | 363/90 |
| ||||
Systolic BP | ||||
Linear Risk | 0.89 (0.82, 0.97) | 1.09 (1.03, 1.16)a | 1.13 (1.02, 1.25) | 1.00 (0.92, 1.10) |
SBP Threshold | 153 (150, 156) | - | 139 (138, 140) | 141 (138, 144) |
10 mm Hg below | 0.77 (0.69, 0.86) | - | 0.56 (0.46, 0.68) | 0.81 (0.67, 0.97) |
10 mm Hg above | 1.29 (1.08, 1.54) | - | 2.00 (1.70, 2.31) | 1.17 (1.02, 1.35) |
| ||||
Diastolic BP | ||||
Linear Risk | 0.92 (0.85, 0.99)a | 1.09 (1.02, 1.16)a | 1.00 (0.81, 1.23) | 1.10 (0.94, 1.28) |
DBP Threshold | - | - | 76 (75, 77) | 76 (74, 78) |
5 mm Hg below | - | - | 0.60 (0.51, 0.72) | 0.83 (0.71, 0.97) |
5 mm Hg above | - | - | 1.57 (1.33, 1.86) | 1.20 (1.07, 1.34) |
No observable change in pattern of log hazard function suggests the use of linear risk estimates
NOTE: Estimates adjusted for age, education, race, sex, heart disease, and diabetes. The presence of APOE ε4 allele adjusted for medication use, and medication use adjusted for APOE ε4 allele estimates